Emergent BioSolutions Inc. (EBS)
NYSE · Healthcare
Emergent BioSolutions Inc. Gross Profit 2009–2025
Emergent BioSolutions Inc. annual/quarterly gross profit history and growth rate from 2009 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Emergent BioSolutions Inc. gross profit for the quarter ending March 31, 2026 was 84.1 M, a 37.10% decrease year-over-year.
- Emergent BioSolutions Inc. gross profit for the twelve months ending March 31, 2026 was 437.0 M, a 25.50% increase year-over-year.
- Emergent BioSolutions Inc. annual gross profit for 2025 was 416.7 M, a 15.02% increase from 2024.
- Emergent BioSolutions Inc. annual gross profit for 2024 was 362.3 M, a 14.07% increase from 2023.
- Emergent BioSolutions Inc. annual gross profit for 2023 was 317.6 M, a 17.08% decrease from 2022.
- Emergent BioSolutions Inc. annual gross profit for 2022 was 383.0 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Emergent BioSolutions Inc. Gross Profit — FAQ
Emergent BioSolutions Inc. (EBS) gross profit over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Emergent BioSolutions Inc.'s gross profit?
Emergent BioSolutions Inc. (EBS) reported gross profit of $417M for fiscal 2025.
Where can I see EBS's gross profit history?
The chart and table above show Emergent BioSolutions Inc.'s gross profit by year and by quarter, including the growth rate.